Danish Scientists Brew Cancer Drug in Yeast Cells

Scientists just turned ordinary yeast into tiny cancer-fighting factories, and it could revolutionize how millions of patients access lifesaving treatment.

A team at the University of Copenhagen cracked the code for producing Taxol, one of the world's most important chemotherapy drugs, entirely inside yeast cells. For decades, making this crucial medication has been expensive, complicated, and hard on the environment.

Taxol treats breast, ovarian, and lung cancers, helping countless patients fight back against disease. But the current production method relies on chemicals, toxic solvents, and material from Pacific yew trees that are increasingly difficult to source.

The Danish researchers identified the last two missing enzymes needed for complete Taxol production in living cells. They cloned genes from yew trees and inserted them into yeast, which then started manufacturing the drug naturally, like microscopic pharmaceutical plants.

Lead researcher Feiyan Liang says this approach could slash production costs by 50 percent. That's a game changer for developing countries where ovarian and other cancers are rising but treatment remains out of reach for many patients.

The Ripple Effect goes far beyond the price tag. Producing Taxol in yeast means dramatically less chemical waste polluting our environment. It protects endangered yew trees from overharvesting. And it allows countries to manufacture the drug locally instead of depending on complex global supply chains that can break down during crises.

The team has already filed a patent and plans to launch a company to scale up production. Their research, published in Nature Synthesis, represents years of painstaking work to understand exactly how yew trees make this remarkable compound.

This isn't just about making medicine cheaper. It's about making hope more accessible to patients everywhere, regardless of where they live or how much money they have.